BIOTRANSPLANT INC
SC 13G, EX-99.B, 2000-06-08
PHARMACEUTICAL PREPARATIONS
Previous: BIOTRANSPLANT INC, SC 13G, EX-99.A, 2000-06-08
Next: BIOTRANSPLANT INC, SC 13G, EX-99.C, 2000-06-08




                                    EXHIBIT B

The name and principal occupation or employment, which in each instance is with
Paramount Capital Asset Management, Inc. ("Paramount Capital") located at 787
Seventh Avenue, 48th Floor, New York, New York, 10019, of each executive officer
and director of Paramount Capital is as follows:

NAME                            PRINCIPAL OCCUPATION

Lindsay A. Rosenwald, M.D.      Chairman of the Board and sole shareholder,
                                Paramount Capital Asset Management, Inc.,
                                Paramount Capital Investments LLC and Paramount
                                Capital, Inc.

Mark C. Rogers, M.D.            President of Paramount Capital Asset

Peter Morgan Kash               Director of Paramount Capital Asset

Dr. Yuichi Iwaki                Director of Paramount Capital Asset Management,
                                Inc., Professor, University of Southern
                                California School of Medicine

Item 2.

During the five years prior to the date hereof, the above person (to the best of
Paramount Capital's knowledge) has not been convicted in a criminal proceeding
(excluding traffic violations or similar misdemeanors). Additionally, during the
five years prior to the date hereof, the above person (to the best of Paramount
Capital's knowledge) has not been a party to a civil proceeding, of a judicial
or administrative body of competent jurisdiction, as a result of which such
person was or is subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to, Federal or
State securities laws or finding any violation with respect to such laws.

Items 3-6.

Please refer to Items 3-6 herein reporting the beneficial ownership.


                                 Page 12 of 15



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission